货号:GS40599
Renvistobart is a humanized IgG1 kappa monoclonal antibody targeting T cell immunoreceptor with Ig and ITIM domains (TIGIT). It blocks TIGIT, an inhibitory checkpoint receptor on T cells and NK cells, to enhance anti-tumor immune responses. It is being evaluated in cancer immunotherapy, often in combination with PD-1/PD-L1 inhibitors.
武汉迈思生物科技有限公司
联系商家时请提及chemicalbook,有助于交易顺利完成!
迈思生物